New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 14, 2012
06:31 EDTEWEdwards Lifesciences downgraded to Sell from Neutral at UBS
UBS downgraded Edwards Lifesciences due to the slower than expected U.S. Sapien launch and European deceleration. Price target lowered to $80 from $95.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for EW

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use